C86.60 Código faturável e específico Primary cutaneous CD30-positive T-cell proliferations not having achieved remission

ICD-10-CM C86.60 identifies “Primary cutaneous CD30-positive T-cell proliferations not having achieved remission” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Capítulo 2: Neoplasms

Instruções do código

Inclusion terms11
  • Lymphomatoid papulosis NOS
  • Lymphomatoid papulosis not having achieved remission
  • Lymphomatoid papulosis with failed remission
  • Primary cutaneous anaplastic large cell lymphoma NOS
  • Primary cutaneous anaplastic large cell lymphoma not having achieved remission
  • Primary cutaneous anaplastic large cell lymphoma with failed remission
  • Primary cutaneous CD30-positive large T-cell lymphoma NOS
  • Primary cutaneous CD30-positive large T-cell lymphoma not having achieved remission
  • Primary cutaneous CD30-positive large T-cell lymphoma with failed remission
  • Primary cutaneous CD30-positive T-cell proliferations NOS
  • Primary cutaneous CD30-positive T-cell proliferations with failed remission

Instruções dos níveis superiores

Capítulos 2 · Neoplasms (C00-D49)

Note8
  • Functional activity
  • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
  • Morphology [Histology]
  • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
  • Primary malignant neoplasms overlapping site boundaries
  • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
  • Malignant neoplasm of ectopic tissue
  • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).

C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)

Excludes 24
  • Kaposi's sarcoma of lymph nodes (C46.3)
  • secondary and unspecified neoplasm of lymph nodes (C77.-)
  • secondary neoplasm of bone marrow (C79.52)
  • secondary neoplasm of spleen (C78.89)

C86 · Other specified types of T/NK-cell lymphoma

Excludes 14
  • anaplastic large cell lymphoma, ALK negative (C84.7-)
  • anaplastic large cell lymphoma, ALK positive (C84.6-)
  • mature T/NK-cell lymphomas (C84.-)
  • other specified types of non-Hodgkin lymphoma (C85.8-)

C86.6 · Primary cutaneous CD30-positive T-cell proliferations

Inclusion terms3
  • Lymphomatoid papulosis
  • Primary cutaneous anaplastic large cell lymphoma
  • Primary cutaneous CD30-positive large T-cell lymphoma
Referências do índice oficial

Histórico oficial de conversão

Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.

Datas de validade 2024-10-01

Atribuição anterior: C86.6

Referências de outros códigos (1)
Histórico

Histórico do código

Última alteração registrada · FY2025

AlteradoSem alteração
FY2025

Válido a partir de

  • Adicionado

Primary cutaneous CD30-positive T-cell proliferations not having achieved remission

Código de diagnóstico faturável

CDC/NCHS · FY2025

Todas as edições (5)

Todas as ediçõesVálido a partir deHistórico do código
FY20252024-10-01Adicionado
FY2025 · 04-012025-04-01Sem alteração tabular
FY20262025-10-01Sem alteração tabular
FY2026 · April2026-04-01Sem alteração tabular
FY20272026-10-01Sem alteração tabular

Esta entrada é um código completo na edição selecionada. A verificação da referência não estabelece adequação clínica nem garante reembolso.